Umpqua Bank Has $2.68 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Umpqua Bank lowered its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 0.6% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 6,591 shares of the company’s stock after selling 42 shares during the period. HCA Healthcare accounts for approximately 1.0% of Umpqua Bank’s holdings, making the stock its 27th largest position. Umpqua Bank’s holdings in HCA Healthcare were worth $2,679,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in HCA. CreativeOne Wealth LLC bought a new position in HCA Healthcare in the 1st quarter valued at about $231,000. Bessemer Group Inc. increased its position in HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after buying an additional 2,584 shares during the period. Empowered Funds LLC increased its stake in shares of HCA Healthcare by 54.3% in the 1st quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock valued at $4,639,000 after purchasing an additional 4,893 shares during the last quarter. Swedbank AB acquired a new stake in HCA Healthcare in the first quarter valued at approximately $95,882,000. Finally, EP Wealth Advisors LLC raised its position in HCA Healthcare by 1.6% in the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock valued at $72,335,000 after purchasing an additional 3,516 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on HCA shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday. TD Cowen dropped their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Finally, UBS Group boosted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $379.11.

Get Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Trading Down 4.0 %

NYSE:HCA traded down $14.68 during mid-day trading on Wednesday, reaching $351.98. 618,300 shares of the company’s stock traded hands, compared to its average volume of 1,163,533. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 12-month low of $226.48 and a 12-month high of $417.14. The firm has a market capitalization of $89.16 billion, a price-to-earnings ratio of 16.46, a PEG ratio of 1.37 and a beta of 1.68. The company has a 50 day moving average price of $392.01 and a 200-day moving average price of $355.77.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.75%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

Insider Activity

In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.70% of the company’s stock.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.